Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 18295446)

1.

No effect of route of exposure (oral; subcutaneous injection) on plasma bisphenol A throughout 24h after administration in neonatal female mice.

Taylor JA, Welshons WV, Vom Saal FS.

Reprod Toxicol. 2008 Feb;25(2):169-76. doi: 10.1016/j.reprotox.2008.01.001. Epub 2008 Jan 17.

2.

Pharmacokinetics of bisphenol A in neonatal and adult CD-1 mice: inter-species comparisons with Sprague-Dawley rats and rhesus monkeys.

Doerge DR, Twaddle NC, Vanlandingham M, Fisher JW.

Toxicol Lett. 2011 Dec 15;207(3):298-305. doi: 10.1016/j.toxlet.2011.09.020. Epub 2011 Sep 29.

PMID:
21983029
3.

The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration.

Pottenger LH, Domoradzki JY, Markham DA, Hansen SC, Cagen SZ, Waechter JM Jr.

Toxicol Sci. 2000 Mar;54(1):3-18.

4.

Age and dose dependency of the pharmacokinetics and metabolism of bisphenol A in neonatal sprague-dawley rats following oral administration.

Domoradzki JY, Thornton CM, Pottenger LH, Hansen SC, Card TL, Markham DA, Dryzga MD, Shiotsuka RN, Waechter JM Jr.

Toxicol Sci. 2004 Feb;77(2):230-42. Epub 2003 Dec 22.

5.

Comparison of serum bisphenol A concentrations in mice exposed to bisphenol A through the diet versus oral bolus exposure.

Sieli PT, Jašarevic E, Warzak DA, Mao J, Ellersieck MR, Liao C, Kannan K, Collet SH, Toutain PL, Vom Saal FS, Rosenfeld CS.

Environ Health Perspect. 2011 Sep;119(9):1260-5. doi: 10.1289/ehp.1003385. Epub 2011 Jun 6.

6.

Pharmacokinetics of bisphenol A in serum and adipose tissue following intravenous administration to adult female CD-1 mice.

Doerge DR, Twaddle NC, Vanlandingham M, Fisher JW.

Toxicol Lett. 2012 Jun 1;211(2):114-9. doi: 10.1016/j.toxlet.2012.03.008. Epub 2012 Mar 20.

PMID:
22465602
7.

Pharmacokinetics of bisphenol A in neonatal and adult rhesus monkeys.

Doerge DR, Twaddle NC, Woodling KA, Fisher JW.

Toxicol Appl Pharmacol. 2010 Oct 1;248(1):1-11. doi: 10.1016/j.taap.2010.07.009. Epub 2010 Jul 23.

PMID:
20655935
8.

Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats.

Prins GS, Ye SH, Birch L, Ho SM, Kannan K.

Reprod Toxicol. 2011 Jan;31(1):1-9. doi: 10.1016/j.reprotox.2010.09.009. Epub 2010 Oct 8.

9.

Extensive metabolism and route-dependent pharmacokinetics of bisphenol A (BPA) in neonatal mice following oral or subcutaneous administration.

Draganov DI, Markham DA, Beyer D, Waechter JM Jr, Dimond SS, Budinsky RA, Shiotsuka RN, Snyder SA, Ehman KD, Hentges SG.

Toxicology. 2015 Jul 3;333:168-78. doi: 10.1016/j.tox.2015.04.012. Epub 2015 Apr 27.

10.

Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach.

Teeguarden JG, Waechter JM Jr, Clewell HJ 3rd, Covington TR, Barton HA.

Toxicol Sci. 2005 Jun;85(2):823-38. Epub 2005 Mar 2.

11.

Pharmacokinetics of bisphenol A in neonatal and adult Sprague-Dawley rats.

Doerge DR, Twaddle NC, Vanlandingham M, Fisher JW.

Toxicol Appl Pharmacol. 2010 Sep 1;247(2):158-65. doi: 10.1016/j.taap.2010.06.008. Epub 2010 Jun 26.

PMID:
20600215
12.

Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure.

Taylor JA, Vom Saal FS, Welshons WV, Drury B, Rottinghaus G, Hunt PA, Toutain PL, Laffont CM, VandeVoort CA.

Environ Health Perspect. 2011 Apr;119(4):422-30. doi: 10.1289/ehp.1002514. Epub 2010 Sep 20. Review. Erratum in: Environ Health Perspect. 2011 Apr;119(4):429. Toutain, Pierre-Louis [added]; Laffont, Céline M [added].

13.

Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration.

Willhite CC, Ball GL, McLellan CJ.

J Toxicol Environ Health B Crit Rev. 2008 Feb;11(2):69-146. doi: 10.1080/10937400701724303. Review.

PMID:
18188738
14.

Disposition of low doses of 14C-bisphenol A in male, female, pregnant, fetal, and neonatal rats.

Kurebayashi H, Nagatsuka S, Nemoto H, Noguchi H, Ohno Y.

Arch Toxicol. 2005 May;79(5):243-52. Epub 2004 Nov 17.

PMID:
15902421
15.

High bioavailability of bisphenol A from sublingual exposure.

Gayrard V, Lacroix MZ, Collet SH, Viguié C, Bousquet-Melou A, Toutain PL, Picard-Hagen N.

Environ Health Perspect. 2013 Aug;121(8):951-6. doi: 10.1289/ehp.1206339. Epub 2013 Jun 12.

16.

Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels.

Rubin BS, Murray MK, Damassa DA, King JC, Soto AM.

Environ Health Perspect. 2001 Jul;109(7):675-80.

17.

Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.

Kawamoto Y, Matsuyama W, Wada M, Hishikawa J, Chan MP, Nakayama A, Morisawa S.

Toxicol Appl Pharmacol. 2007 Oct 15;224(2):182-91. Epub 2007 Jul 12.

PMID:
17698157
18.

Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.

Kurebayashi H, Betsui H, Ohno Y.

Toxicol Sci. 2003 May;73(1):17-25. Epub 2003 Apr 15.

19.

Toxicokinetics of bisphenol A in female DA/Han rats after a single i.v. and oral administration.

Upmeier A, Degen GH, Diel P, Michna H, Bolt HM.

Arch Toxicol. 2000 Oct;74(8):431-6.

PMID:
11097379
20.

Prediction and evaluation of route dependent dosimetry of BPA in rats at different life stages using a physiologically based pharmacokinetic model.

Yang X, Doerge DR, Fisher JW.

Toxicol Appl Pharmacol. 2013 Jul 1;270(1):45-59. doi: 10.1016/j.taap.2013.03.022. Epub 2013 Apr 6.

PMID:
23566954
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk